Biorestorative Therapies, Inc. (BRTX) vs Oragenics, Inc. (OGEN)
- Biorestorative Therapies, Inc. BRTX 1.52 +4.11%
- Oragenics, Inc. OGEN 0.43 −2.27%
Biorestorative Therapies, Inc. and Oragenics, Inc. are both Biotechnology companies. Biorestorative Therapies, Inc. and Oragenics, Inc. are of similar size ($2.0M and $2.0M). Biorestorative Therapies, Inc. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Biorestorative Therapies, Inc. grew revenue faster over the last twelve months: −8.47% against −75.1%. Oragenics, Inc. has the higher net margin (0.00% vs −3,089.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Biorestorative Therapies, Inc. leads on 9 and Oragenics, Inc. on 7.
Valuation
Profitability
| Metric | BRTX | OGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.09% | 19.89% | 65.16% |
| Operating margin | (3,974.66%) | 0.00% | 0.00% |
| Net margin | (3,089.30%) | 0.00% | 0.00% |
| Free cash flow margin | (3,302.04%) | 0.00% | 0.00% |
| Return on equity | (241.50%) | (1,307.07%) | (56.36%) |
| Return on assets | (147.75%) | (264.23%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack